Please login to the form below

Not currently logged in
Email:
Password:

vaccines

This page shows the latest vaccines news and features for those working in and with pharma, biotech and healthcare.

Neoantigen player Achilles gets OK for first clinical trial

Neoantigen player Achilles gets OK for first clinical trial

It’s operating in a busy field in immuno-oncology, with a clutch of companies focusing on neoantigens as a way to tackle cancer using drug, vaccine or cell therapy approaches.

Latest news

  • Industry pleads for compromise after Brexit defeat Industry pleads for compromise after Brexit defeat

    The focus of pharmaceutical companies is on making sure that medicines and vaccines get to patients whatever the Brexit outcome,” added Thompson.

  • GSK upbeat on its return to oncology market GSK upbeat on its return to oncology market

    a ‘pure play’ pharma and vaccines company. ... Nevertheless, there is expected to be strong performances from its Shingrix vaccine and next-generation respiratory drug Ellipta, which have both been the focus of GSK’s new drive towards commercial

  • Moderna CEO makes case for firm’s lofty valuation Moderna CEO makes case for firm’s lofty valuation

    studies of candidates for respiratory syncytial virus (RSV) and a personalised cancer vaccine partnered with Merck &Co/MSD also at the planning stage. ... Other new studies coming up are phase 1 assessments of a triplet immuno-oncology drug (targeting

  • Pharma’s confidence in Brexit deal falls as vote looms Pharma’s confidence in Brexit deal falls as vote looms

    The latest guidance represents a ‘ramping up’ of no deal plans in seven key areas, namely: the supply of medicines and vaccines; the supply of medical devices and clinical consumables; the

  • GSK and Pfizer to create combined consumer health titan GSK and Pfizer to create combined consumer health titan

    Spin-out will allow GSK to focus on prescription drugs and vaccines. ... clear pathway forward for GSK to create a new global pharmaceuticals/vaccines company, with an R&D approach focused on science related to the immune system, use of genetics and

More from news
Approximately 93 fully matching, plus 975 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 4 fully matching, plus 80 partially matching documents found.

Latest appointments

More from appointments
Approximately 5 fully matching, plus 61 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 6 fully matching, plus 23 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics